![]() |
|
|

*
Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157,
Department of Neuroscience and Anatomy and
**
Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, PA 17033
3To whom correspondence should be addressed at Wake Forest University School of Medicine, Department of Biochemistry, Medical Center Boulevard, Winston-Salem, NC 27157. E-mail: shutson{at}wfubmc.edu.
A novel hypothesis for the role of branched-chain amino acids
(BCAA) in regulating levels of the major excitatory neurotransmitter
glutamate in the central nervous system is described. It is postulated
that the branched-chain aminotransferase (BCAT) isoenzymes
(mitochondrial BCATm and cytosolic BCATc) are localized in different
cell types and operate in series to provide nitrogen for optimal rates
of de novo glutamate synthesis. BCAA enter the astrocyte where
transamination is catalyzed by BCATm, producing glutamate and
branched-chain
-keto acids (BCKA). BCKA, which are poorly
oxidized in astrocytes, exit and are taken up by neurons. Neuronal
BCATc catalyzes transamination of the BCKA with glutamate. The
products, BCAA, exit the neuron and return to the astrocyte. The
-ketoglutarate product in the neurons may undergo reductive
amination to glutamate via neuronal glutamate dehydrogenase. Operation
of the shuttle in the proposed direction provides a mechanism for
efficient nitrogen transfer between astrocytes and neurons and
synthesis of glutamate from astrocyte
-ketoglutarate. Evidence in
favor of the hypothesis is: 1) The two BCAT isoenzymes
appear to be localized separately in the neurons (BCATc) or in the
astroglia (BCATm). 2) Inhibition of the shuttle in the
direction of glutamate synthesis can be achieved by inhibiting BCATc
using the neuroactive drug gabapentin. Although gabapentin does not
inhibit BCATm, it does block de novo glutamate synthesis from
-ketoglutarate. 3) Conversely, gabapentin stimulates
oxidation of glutamate. Inhibition of BCATc may allow BCKA to
accumulate in the astroglia, thus facilitating conversion of glutamate
to
-ketoglutarate.
KEY WORDS: branched-chain amino acids transamination glutamate neurotransmitter brain
This article has been cited by other articles:
![]() |
J. T. Brosnan and M. E. Brosnan Branched-Chain Amino Acids: Enzyme and Substrate Regulation J. Nutr., January 1, 2006; 136(1): 207S - 211S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yudkoff, Y. Daikhin, I. Nissim, O. Horyn, B. Luhovyy, A. Lazarow, and I. Nissim Brain Amino Acid Requirements and Toxicity: The Example of Leucine J. Nutr., June 1, 2005; 135(6): 1531S - 1538S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Hutson, A. J. Sweatt, and K. F. LaNoue Branched-Chain Amino Acid Metabolism: Implications for Establishing Safe Intakes J. Nutr., June 1, 2005; 135(6): 1557S - 1564S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Koehnle, M. C. Russell, A. S. Morin, L. F. Erecius, and D. W. Gietzen Diets Deficient in Indispensable Amino Acids Rapidly Decrease the Concentration of the Limiting Amino Acid in the Anterior Piriform Cortex of Rats J. Nutr., September 1, 2004; 134(9): 2365 - 2371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Sweatt, M. Wood, A. Suryawan, R. Wallin, M. C. Willingham, and S. M. Hutson Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E64 - E76. [Abstract] [Full Text] |
||||
![]() |
N. Vanacore, N. Scarmeas, and L. P. Rowland Premorbid weight, body mass, and varsity athletics in ALS Neurology, October 14, 2003; 61(7): 1024 - 1025. [Full Text] [PDF] |
||||